Longr.io Logo - Your Guide to Longevity and Anti-Aging Science

“Electric Longevity Medicine” with $12M Backing

Today delve into the latest technological breakthroughs at the intersection of neurotechnology and longevity healthcare. Our focus is squarely on how these innovations are not merely extensions of existing medical practices but represent fundamental shifts in our approach to health and wellness.  We examine the potential of these developments to redefine the parameters of healthcare, offering insights into their implications for both individual well-being and broader societal health outcomes.
Articles showcasing growth in longevity investment sectors.
Investing in Longevity: Financial Strategies for a Longer Life.

Today delve into the latest technological breakthroughs at the intersection of neurotechnology and longevity healthcare. Our focus is squarely on how these innovations are not merely extensions of existing medical practices but represent fundamental shifts in our approach to health and wellness. 

We examine the potential of these developments to redefine the parameters of healthcare, offering insights into their implications for both individual well-being and broader societal health outcomes.

We begin with Elemind’s introduction of a neurotech wearable that leverages artificial intelligence to modulate brainwaves for therapeutic purposes. This technology exemplifies the move towards non-invasive, personalized healthcare solutions that promise greater efficacy and fewer side effects than traditional pharmaceuticals. By directly influencing neurological functions, Elemind opens up new avenues for treating a range of conditions, from sleep disorders to Parkinson’s disease, showcasing the transformative potential of neurotechnology in healthcare.

Next, we shift our focus to Generation Lab’s pioneering approach to aging diagnostics. Their development of an at-home biological age test, based on the analysis of molecular disbalance, illustrates the growing emphasis on preventive healthcare. By providing a nuanced understanding of individual aging processes, Generation Lab offers a proactive model of health management, where early detection and personalized intervention strategies can significantly impact healthspan and disease prevention.

Lastly, we explore the controversial Enhanced Games initiative, a clear departure from conventional sports competitions, aiming to push the boundaries of human performance through scientific and technological enhancements. This venture challenges traditional notions of fairness and health in competitive sports, proposing a future where the integration of technology and biology enhances human capabilities.

Together, these topics underscore the dynamic and multifaceted nature of technological advancements in the longevity healthcare sector. They highlight a transition towards more personalized, proactive, and technologically integrated approaches to health and wellness, signaling a significant evolution in how we understand and manage the human body’s potential.

Let’s dive in …

Elemind Raises $12M for ‘Electric Medicine’

Elemind’s recent unveiling of a neurotech wearable that incorporates artificial intelligence to modulate brainwaves marks a significant milestone in the fusion of technology and healthcare. With a successful $12 million funding round, the company has set its sights on transforming the treatment landscape for neurological conditions. 

This AI-enhanced device, designed for non-invasive brainwave stimulation, promises to offer a new therapeutic pathway for conditions traditionally managed with pharmaceuticals, including sleep disorders and motor tremors associated with diseases like Parkinson’s.

The technology underpinning Elemind’s wearable is a testament to the potential of neurotechnology to provide tailored healthcare solutions. By analyzing and modulating brainwaves, the device offers a personalized approach to treatment, capable of inducing sleep, suppressing tremors, and potentially enhancing cognitive functions. Such capabilities not only demonstrate the wearable’s versatility but also its potential to improve quality of life for individuals with a variety of neurological conditions.

Elemind’s collaborative efforts with leading research institutions and its robust backing from notable investors underscore the confidence in its innovative approach. The company’s strategy to conduct preliminary experiments for validating its technology highlights a commitment to scientific rigor and effectiveness.

As neurotechnology continues to evolve, Elemind’s wearable represents a pioneering step towards realizing the full potential of AI in enhancing human health and well-being.

Read the full article here.


This exclusive first edition has a complete sector breakdown, and an introduction to some of the key things professional longevity investors are looking at.

We’re demystifying the sector, and providing inside access to the most promising companies.


Generation Lab Emerges from Stealth with New Biological Age Test

Generation Lab, emerging from stealth with a novel biological age test, represents a forward leap in the quest for extending human healthspan. This San Francisco-based startup, co-founded by renowned researchers Irina Conboy and advised by George Church, introduces an at-home cheek-swab test that measures molecular disbalance, a marker for aging and disease risk. This innovative approach seeks to go beyond traditional biological age assessments by focusing on molecular biological noise, offering a more nuanced understanding of the aging process.

At the core of Generation Lab’s offering is the promise of early detection and personalized intervention. For a yearly fee, individuals can access a series of tests that not only pinpoint their biological age but also guide them towards clinical and lifestyle changes aimed at mitigating aging and disease onset. This model of proactive healthcare, rooted in precise molecular measurements, has the potential to significantly alter the landscape of aging research and treatment.

The support from high-profile investors and the anticipation surrounding Generation Lab’s product launch reflect the growing interest in and the critical need for advanced diagnostics in the longevity sector. By translating cutting-edge research into accessible health diagnostics, Generation Lab stands at the forefront of a movement towards personalized, data-driven health management strategies designed to optimize individual healthspan and combat aging at its molecular roots.

Read the full article here.

Could Billionaire-Backed Enhanced Games Benefit Human Longevity?

The introduction of the Enhanced Games, backed by visionary investors like Peter Thiel and Christian Angermayer, challenges traditional paradigms of athletic competition by embracing technological and biological enhancements. This initiative, which foregoes drug testing in favor of celebrating scientific advancements in human performance, raises profound questions about the future of sports, fairness, and the ethical boundaries of human enhancement.

At its heart, the Enhanced Games aim to showcase how science can extend the limits of human capabilities, suggesting a future where the integration of technology and biology not only enhances athletic performance but also contributes to the broader field of longevity science. By prioritizing athlete safety and pushing the boundaries of conventional sports, the Enhanced Games offer a unique platform for exploring the potential of enhancements in improving human health and performance.

The controversy surrounding the Enhanced Games underscores the complex ethical considerations that accompany the advancement of human enhancement technologies. However, it also highlights a growing recognition of the potential benefits of such technologies, not just in the realm of sports but in the pursuit of improved health and longevity. 

As we navigate these ethical landscapes, the Enhanced Games represent a pivotal moment in the ongoing dialogue about the role of science in expanding human potential and redefining the limits of what is possible.

Read the full article here.

In this edition of Longr Reads, we’ve covered the frontier of neurotechnology and longevity healthcare, exploring innovations that promise to redefine our approach to health and aging. 

We’ve examined Elemind’s venture into neurotech wearables, Generation Lab’s novel biological age test, and the controversial yet pioneering Enhanced Games. Each narrative contributes to a broader understanding of how technology intersects with healthcare to open new possibilities for treatment, prevention, and human enhancement.

Elemind’s development underscores the growing importance of precision medicine, highlighting a shift towards treatments tailored to individual physiological responses. This approach not only challenges traditional pharmaceutical modalities but also aligns with a broader trend towards non-invasive, personalized healthcare solutions. Generation Lab’s foray into aging diagnostics further exemplifies this trend, offering insights into the molecular mechanisms of aging and providing a framework for preemptive health management strategies.

The Enhanced Games, meanwhile, illuminate the ethical and societal implications of integrating technology with human biology. This initiative serves as a microcosm of the broader debates surrounding human enhancement, pushing the boundaries of what is considered acceptable in the pursuit of improved health and performance.

Collectively, these developments signal a paradigm shift in our understanding and management of health, aging, and human capabilities.They underscore the potential of technological advancements to not only extend life but also to enhance the quality of living. 

As we continue to navigate the complexities and opportunities presented by these innovations, the insights gleaned from today’s discussions will undoubtedly play a crucial role in shaping the future of longevity healthcare.

Until next time,

The Longr Reads Team

“The greatest glory in living lies not in never falling, but in rising every time we fall.”

Nelson Mandela

Longr Reads’ of the Week

Follow Us

Longr Read

Our daily newsletter covers the latest longevity investment, technology, scientific, and lifestyle developments.

Newsletter Form

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic.